
Actuate Therapeutics CEO Daniel M. Schmitt had 272,056 restricted stock units (RSUs) vest on August 14, 2026. To cover federal and state tax obligations, 120,521 shares of common stock were withheld by the company at a per-share value of $1.01. This transaction is consistent with prior grants and leaves Schmitt with direct and indirect holdings, including shares held in several irrevocable family trusts.
Stock Titan
Original source

